SEC Settles Insider Trading Suit Over Pharma Deal
A former hedge fund manager and an executive with a New Jersey-based pharmaceutical company, both facing insider trading charges tied to AstraZeneca's acquisition of MedImmune Inc. in 2007, have agreed to...To view the full article, register now.
Already a subscriber? Click here to view full article